ZFP36 and viral infectious disease: Studies involving the ARE-BP tristetraprolin (TTP) have largely focused on its role in lipopolysaccharide (LPS)-treated myeloid cells, with little understanding of its role in type I/type III IFN regulation or following viral infection.